| INTRODUCTION
Zika virus (ZIKV), a flavivirus primarily transmitted by the Aedes aegypti mosquito, was first isolated in a sentinel rhesus macaque monkey in the Zika Forest of Uganda in 1947 (Dick, Kitchen, & Haddow, 1952) . Serological studies in humans identified a widespread presence in Africa and parts of Asia including Cambodia, India, Thailand, North Vietnam, Philippines, and Malaysia (Duong et al., 2017; Heang et al., 2012; Olson et al., 1983; Sather, Schrack, & Hammon, 1958; Smithburn, Kerr, & Gatne, 1953; Wikan & Smith, 2017) . Most persons with ZIKV infection are asymptomatic; among those who report symptoms, low grade fever, malaise, erythematous rash, arthritis or arthralgia, and conjunctivitis are most commonly reported (Baud, Gubler, Schaub, Lanteri, & Musso, 2017) .
Because it is a mild and often asymptomatic illness, ZIKV infection received little attention until an increase in the number of infants born with microcephaly was noted following an outbreak in Brazil in 2015 (de Araújo et al., 2016; Rasmussen, Jamieson, Honein, & Petersen, 2016; Schuler-Faccini et al., 2016) . Shortly thereafter, a similar association was retrospectively identified following the 2013-2014 outbreak in French Polynesia (Cauchemez et al., 2016; Musso et al., 2017) . Subsequently a characteristic pattern of defects was described among infants born to mothers with ZIKV infection during pregnancy, now recognized as congenital Zika syndrome (CZS) (del Campo et al., 2017; Moore et al., 2017) . Common features of CZS include brain anomalies (cortical loss with associated ventriculomegaly, subcortical calcifications, corpus callosum abnormalities, hypoplasia of the cerebellum and brainstem) (de Fatima Vasco Aragao et al., 2016) , ophthalmologic anomalies (optic nerve abnormalities, macular scarring, focal pigmentary retinal mottling, chorioretinal atrophy) (de Paula Freitas et al., 2016; Yepez et al., 2017) , as well as neurological sequelae (cognitive and motor disabilities, seizures, and difficulty feeding) . In particular, the combination of the following five characteristics is unique to CZS and not seen in other congenital infections, genetic syndromes, and acquired brain injuries: (1) fetal brain disruption sequence (FBDS) phenotype, which consists of a partially collapsed skull with overlapping sutures, prominent occiput, and scalp rugae; (2) cortical loss with unique subcortical calcifications; (3) ocular anomalies of macular scarring and focal pigmentary retinal mottling; (4) isolated or multiple congenital contractures; and (5) early hypertonia with extrapyramidal involvement manifesting as tremors and posturing .
In this report, two children, ages 7 (Case 1) and 8 years (Case 2), with a phenotype consistent with CZS are described. In both cases, the mothers lived near Phnom Penh, Cambodia during their pregnancies in 2010-2011 and 2009 , respectively. Mosquito-borne transmission of human ZIKV infection has been confirmed in southern Cambodia during this time period (Duong et al., 2017; Heang et al., 2012) . The purpose of this paper is twofold: (1) to provide additional support for the evolving premise that CZS occurred prior to 2013 in regions where ZIKV was circulating, and (2) to describe the clinical and neurodevelopmental status of two older children with possible CZS.
| METHODS
Case 1 presented in 2016 at 5 years of age to a pediatric infectious disease clinic in the United States for evaluation of possible CZS. The mother of Case 1 became an acquaintance of the mother of Case 2 through a social networking forum when they noted similarities in their pregnancies and atypical features of the two children. The mothers were interviewed and available medical records were reviewed for both cases, including information on prenatal history, clinical presentation at birth, laboratory evaluation, and neuroimaging in the first year of life. Birth weight and head circumference measurements were compared to the Fenton 2013 growth chart (Fenton & Kim, 2013) . for neutralizing antibodies to dengue 1, dengue 2, and ZIKV by plaque reduction neutralization test (PRNT). A PRNT using a 90% cutoff value with a titer ≥10 indicated the presence of virus specific neutralizing antibodies. In addition, serum specimens were tested with an experimental microsphere-based immunoassay (MIA) for detection of IgM and IgG antibodies to ZIKV envelope and NS1 antigens, which are thought to have less cross-reactivity to other flaviviruses than antibodies to the envelope protein Steinhagen et al., 2016) . This assay, based on a MIA for West Nile and St. Louis encephalitis viruses (Johnson et al., 2007) , was modified to incorporate three bead sets (NS1 antigen, normal antigen, and Zika antigen) (Bio-Rad Laboratories) and exclude the IgG depletion step. Table 1 lists the clinical features of Case 1.
Testing at time of birth for common congenital infections was negative (Table 2) , including Toxoplasma gondii, cytomegalovirus, herpes simplex virus, rubella, and Treponema pallidum. At three years of age, she was also tested for evidence of prior parvovirus B19 infection, which was negative. Chromosomal analysis showed a normal 46, XX karyotype. In 2017, ZIKV serology testing for Case 1 was negative for both IgM and IgG. However, ZIKV serology testing for the mother was consistent with a prior infection with positive IgG and negative IgM. The mother's PRNT demonstrated high neutralizing antibody titers to ZIKV (Table 2) .
Family history is unremarkable with one sister, age 4 years, who is in good health and has typical development. The mother's travel history prior to pregnancy with Case 1 included India and Southeast Asia. Since the family's return to the United States when the patient was 8 months of age, they have traveled to Nicaragua for 10 days in February 2016. 
| Current Developmental Status
Case 1 has severe global developmental delay. The Minnesota Child Development Inventory at 6 years of age demonstrated the following developmental levels: gross motor (5 months), fine motor (5 months), expressive language (6 months), receptive language (15 months), and social (7 months) (Ireton & Thwing, 1985) . She continues to have profound central hypotonia with peripheral hypertonia and is unable to sit or hold her head up without support. Although she can vocalize vowel sounds, she is nonverbal. In the last year, she has started working with a communication board. With the communication board, she FIGURE 3 Brain MRI for Case 1 at age 6 months (A to C) and Case 2 at age 7 months (D to F). Neuroimaging for both children demonstrate microcephaly, irregular nodular cortex consistent with polymicrogyria (circles), reduced white matter volume in the supratentorial region (long arrows), increased T2 hyperintensity of white matter (arrows), ventriculomegaly (carets), and severe thinning of the corpus callosum (asterisks) in the axial T2 images (A, D), coronal T2 images (B, E), and sagittal T1 images (C, F) has demonstrated consistent recognition of around 40 words and is able to make some simple choices between two objects. Table 1 .
Screening at birth for congenital infections (including Toxoplasma gondii, cytomegalovirus, herpes simplex virus, rubella, and Treponema pallidum) was negative. He has a 46, XY normal karyotype ( Table 2 ).
The mother of Case 2 was tested in 2017. The results were consistent with a prior ZIKV infection with a positive IgG and a negative IgM;
she also had high neutralizing antibody titers to ZIKV on the PRNT (Table 2) . ZIKV serology testing was negative for Case 2.
The patient has three older siblings and one younger sibling with no developmental problems. Since the family's return to the United States when Case 2 was 7 months of age, they have only taken brief trips to Canada. 
| Medical History

| Current Developmental Status
Case 2 is followed by a neurodevelopmental specialist and palliative care; he receives physical, occupational, and speech therapy for his severe global developmental delay. At age 8, Case 2 is unable to sit or hold his head up without support. When supported upright, he is able to turn his head side to side. He is similarly able to vocalize sounds, but has no vocabulary. He has not attempted communicating with alternative methods (e.g., communication boards). Per mother, he expresses excitement (from vocalization of sounds, to giggles and smiles) when he recognizes familiar people and enjoys being with his family.
| DISCUSSION
CZS is the most likely etiology for the phenotype observed in these children given the epidemiologic and clinical evidence suggesting maternal ZIKV infection during pregnancy, the infant features and radiologic imaging consistent with CZS, and the lack of another identified etiology. The presence of both a rare exposure (prior maternal ZIKV infection) and a rare outcome (CZS-like phenotype) in two separate cases with a similar history consistent with maternal ZIKV infection during pregnancy strongly suggests that these are two infants with CZS following maternal infections in Cambodia.
Among infectious etiologies, congenital infection is the most commonly associated with the FBDS phenotype and intracranial calcifications (Alarcon et al., 2013) . At the time of birth, both children tested negative for the common congenital infections. However, testing did not include congenital lymphocytic choriomeningitis virus (LCMV), which is also capable of producing congenital microcephaly with calcifications (Bonthius, 2012) . Regardless, both congenital cytomegalovirus infection and congenital LCMV are associated with periventricular calcifications rather than the unique subcortical calcifications found in CZS . The sensorineural hearing loss in Case 1 is nonspecific and found in many congenital infections. In infants with CZS, 5-9% are affected by sensorineural hearing loss (Leal et al., 2016) .
Genetic etiologies for congenital microcephaly were considered as well. JAM3 mutations can result in microcephaly, FBDS, and subependymal calcifications, but also have the distinctive feature of progressive multifocal intraparenchymal hemorrhage with subsequent massive cystic degeneration (Akawi et al., 2013; Mochida et al., 2010) . AicardiGoutieres syndrome shares features of microcephaly, intracranial calcifications, and neuromuscular sequelae of spasticity and dystonia. However, it is also associated with systemic signs and symptoms of hepatosplenomegaly, hepatitis, thrombocytopenia, and chilblains, which neither children display (Rice et al., 2007) . A mutation in NDE1 or ANKLE2 genes causes congenital microcephaly, but is not associated with intracranial calcifications (Alkuraya et al., 2011; Barkovich et al., 2012; Edwards, Sherr, Barkovich, & Richards, 2014) . While genetic conditions cannot be definitively excluded without comprehensive genetic testing, such as whole genome sequencing, the epidemiological, clinical, and neuroimaging data in these cases strongly implicate CZS.
It is difficult to definitively prove CZS retrospectively. Zika serology testing could not be performed on stored patient specimens collected at birth, and when tested at 6 and 7 years of age, both children had negative Zika antibodies. Negative IgM antibodies of a remote congenital infection is not unexpected; follow-up data of infants with CZS demonstrate loss of Zika IgM antibodies by six months of age (Adebanjo et al., 2017) . Furthermore, several cases of CZS have been reported in which the serum was negative for IgM despite a positive CSF IgM (de Araújo et al., 2016; Tenorio Cordeiro, Pena, Brito, Gil, & Marques, 2016) . Currently, there are no published data available on persistence of IgG and neutralizing antibodies in children with CZS.
However, absence of IgG antibodies in older children with other congenital infections has been documented in serology follow-up studies, which is not surprising given the immature immune system of a fetus (M. L. Kumar et al., 1984; M. L. Kumar, Nankervis, & Gold, 1973; Cooper, Florman, Ziring, & Krugman, 1971; Mcauley et al., 1994; Thomas et al., 1993) . In a prospective cohort of 270 children with congenital rubella and yearly serology testing, 18% of the children seroreverted by five years of age (Cooper, Florman, Ziring, & Krugman, 1971) . Another prospective cohort of 14 children with congenital cytomegalovirus infection demonstrated a clear decline in antibodies among all participants, but undetectable antibodies in only 2 children by four years of age (M. L. Kumar et al., 1973) . It is possible that children with congenital cytomegalovirus infection are more likely to retain detectable antibodies due to prolonged viral shedding, reactivation, or reinfection from the general population (Noyola et al., 2000) .
In congenital toxoplasmosis, there are reports of children that never develop IgG antibodies (Mcauley et al., 1994) . Extrapolating from these other congenital infections, absence of Zika IgG antibodies in older children is not inconsistent with CZS, particularly given the clinical presentation and neuroimaging. Rather, these studies emphasize the difficulties in diagnosing older children with a congenital infection, including CZS.
A recent retrospective study of six infants with microcephaly born in Hawaii found an association between maternal ZIKV infection and infant microcephaly as early as 2009, although further phenotypic description of these infants with possible CZS was not provided (M. Kumar et al., 2017) . This raises the question that if CZS existed prior to the 2013 French Polynesia outbreak, why was it not recognized earlier? Phylogeny performed on the French Polynesia and Brazil strains revealed that both outbreaks were of the Asian lineage, confirming a westward movement of ZIKV over the years (Lanciotti, Lambert, Holodniy, Saavedra, & del Carmen Castillo Signor, 2016) . A viral seroprevalence screening program in the 1950s demonstrated ZIKV seropositivity in India and Thailand (Pond, 1983; Smithburn et al., 1953) . Although the actual ZIKV seroprevalence is likely lower than the reported rates given the cross-reactivity of flavivirus antibodies, a low level of ZIKV activity may have been present in these regions. In several congenital infections such as toxoplasma, rubella, and parvovirus, maternal seropositivity is considered protective against intrauterine infections (Dontigny et al., 2008; Edmunds et al., 2000) . Thus, the difference in the ZIKV maternal immunity rate between the ZIKV circulation regions of Southeast Asia compared to the naïve population of Brazil is one possible hypothesis for the dramatic increase in the birth prevalence of microcephaly and the eventual identification of the CZS.
Another hypothesis to explain the increase in microcephaly is an increase in the neurovirulence of the Asian lineage ZIKV due to mutations in the virus as it moved westward. A study using a mouse model provides support for this theory as a single mutation in a premembrane protein in the contemporary ZIKV strain is responsible for increased virulence and mortality compared to a Cambodian ZIKV strain isolated in 2010 (Yuan et al., 2017) . The study found that intracerebral injection of the Cambodian strain in the mice led to a 16.7%
mortality rate compared to a 100% mortality rate seen with the contemporary ZIKV strain. The 2010 Cambodian strain was also associated with a less severe microcephaly phenotype than the contemporary ZIKV strain. However, it is difficult to make direct inferences given the method of infection by intracerebral injection and the marked difference in mortality associated with the contemporary strain between the mouse and human.
A recent review of the medical literature on infants with evidence of CZS found that 54% had epilepsy and 100% had motor abilities consistent with cerebral palsy (Pessoa et al., 2018) . However, as the current CZS cohort in Brazil is still young, very little is known about 
